Smith SS - Search Results

1

Presurgical Biomarker Performance in the Detection of Gleason Upgrading in Prostate Cancer.

Wittig K, Yamzon JL, Smith DD, Jeske DR, Smith SS. Wittig K, et al. Among authors: smith dd, smith ss. Cancer Epidemiol Biomarkers Prev. 2016 Dec;25(12):1643-1645. doi: 10.1158/1055-9965.EPI-16-0488. Epub 2016 Aug 19. Cancer Epidemiol Biomarkers Prev. 2016. PMID: 27543619 Free PMC article.

2

Performance of a single assay for both type III and type VI TMPRSS2:ERG fusions in noninvasive prediction of prostate biopsy outcome.

Clark JP, Munson KW, Gu JW, Lamparska-Kupsik K, Chan KG, Yoshida JS, Kawachi MH, Crocitto LE, Wilson TG, Feng Z, Smith SS. Clark JP, et al. Among authors: smith ss. Clin Chem. 2008 Dec;54(12):2007-17. doi: 10.1373/clinchem.2008.108845. Epub 2008 Oct 23. Clin Chem. 2008. PMID: 18948370 Free PMC article.

3

The influence of PSA-RNA yield on the analysis of expressed prostatic secretions (EPS) for prostate cancer diagnosis.

Whelan C, Crocitto L, Kawachi M, Chan K, Smith D, Wilson T, Smith S. Whelan C, et al. Can J Urol. 2013 Feb;20(1):6597-602. Can J Urol. 2013. PMID: 23433128 Free PMC article.

4

Expressed prostatic secretion biomarkers improve stratification of NCCN active surveillance candidates: performance of secretion capacity and TMPRSS2:ERG models.

Whelan C, Kawachi M, Smith DD, Linehan J, Babilonia G, Mejia R, Wilson T, Smith SS. Whelan C, et al. Among authors: smith dd, smith ss. J Urol. 2014 Jan;191(1):220-6. doi: 10.1016/j.juro.2013.05.019. Epub 2013 May 10. J Urol. 2014. PMID: 23669563 Free PMC article.

5

Stromal response to prostate cancer: nanotechnology-based detection of thioredoxin-interacting protein partners distinguishes prostate cancer associated stroma from that of benign prostatic hyperplasia.

Singer E, Linehan J, Babilonia G, Imam SA, Smith D, Loera S, Wilson T, Smith S. Singer E, et al. PLoS One. 2013 Jun 6;8(6):e60562. doi: 10.1371/journal.pone.0060562. Print 2013. PLoS One. 2013. PMID: 23762225 Free PMC article.

6

Maximizing the usefulness of statistical classifiers for two populations with illustrative applications.

Jeske DR, Smith S. Jeske DR, et al. Stat Methods Med Res. 2018 Aug;27(8):2344-2358. doi: 10.1177/0962280216680244. Epub 2016 Dec 5. Stat Methods Med Res. 2018. PMID: 27920365

7

Two-stage classifiers that minimize PCA3 and the PSA proteolytic activity testing in the prediction of prostate cancer recurrence after radical prostatectomy.

Jeske DR, Linehan JA, Wilson TG, Kawachi MH, Wittig K, Lamparska K, Amparo C, Mejia R, Lai F, Georganopoulou D, Smith SS. Jeske DR, et al. Among authors: smith ss. Can J Urol. 2017 Dec;24(6):9089-9097. Can J Urol. 2017. PMID: 29260633

8

Construction, visualization and application of neutral zone classifiers.

Jeske DR, Zhang Z, Smith S. Jeske DR, et al. Stat Methods Med Res. 2020 May;29(5):1420-1433. doi: 10.1177/0962280219863823. Epub 2019 Jul 18. Stat Methods Med Res. 2020. PMID: 31317826

9

Prostate cancer molecular markers GSTP1 and hTERT in expressed prostatic secretions as predictors of biopsy results.

Crocitto LE, Korns D, Kretzner L, Shevchuk T, Blair SL, Wilson TG, Ramin SA, Kawachi MH, Smith SS. Crocitto LE, et al. Among authors: smith ss. Urology. 2004 Oct;64(4):821-5. doi: 10.1016/j.urology.2004.05.007. Urology. 2004. PMID: 15491741

10

Biomarker identification with ligand-targeted nucleoprotein assemblies.

Singer EM, Crocitto LE, Choi Y, Loera S, Weiss LM, Imam SA, Wilson TG, Smith SS. Singer EM, et al. Among authors: smith ss. Nanomedicine (Lond). 2011 Jun;6(4):659-68. doi: 10.2217/nnm.11.22. Nanomedicine (Lond). 2011. PMID: 21718176 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

568 results

Search Page

Filters